معرفی
Dr. Yang Zhou is an Associate Research Scientist and Associate Director for Program Development at the Yale Cancer Center, affiliated with Yale University's School of Medicine, Department of Internal Medicine. With a PhD and MPH in Chronic Disease Epidemiology from Yale, her research focuses on cancer survivorship, particularly the effects of exercise and lifestyle interventions on quality of life, biomarkers, and clinical outcomes in breast, ovarian, and lung cancer patients. She leads studies such as the Women’s Activity and Lifestyle Study (WALC) and the Lifestyle, Exercise, and Nutrition (LEAN) study, investigating physical activity’s role in managing cancer-related symptoms and improving survival. Dr. Zhou collaborates with prominent oncologists and epidemiologists, including Brenda Cartmel, Harvey Risch, and Roy Herbst. Her work has been featured in high-impact journals like the Journal of Clinical Oncology and Gynecologic Oncology.
Education: PhD in Chronic Disease Epidemiology, Yale University (2014); MPH in Chronic Disease Epidemiology, Yale School of Public Health (2010).
Research Interests: Exercise interventions in oncology, biomarker analysis, survivorship care, clinical trial design, and epidemiological studies of cancer outcomes. Her studies emphasize translating lifestyle modifications into clinical practice to improve patient outcomes and reduce treatment-related complications.
Key Contributions: Pioneering work on exercise adherence in aromatase inhibitor therapy for breast cancer, demonstrating benefits of weight loss on telomere length in breast cancer patients, and evaluating diagnostic methods for lymphedema in ovarian cancer survivors. She actively participates in program development at the Yale Cancer Center, enhancing translational research and interdisciplinary collaboration.
Current clinical trial involvement includes studies on anti-cancer therapy mechanisms and resistance (HIC ID 1603017333). Awards include recognition as part of YCC and Smilow Cancer Hospital awardees for her contributions to oncology research.